Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the pembrolizumab and BCG trial is displayed with its study details, eligibility criteria, outcomes, and contact information, replacing a 403 error page.
    Difference
    42%
    Check dated 2026-11-08T11:36:12.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden response rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-01T12:25:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner about NIH terminology changes appears above the ClinicalTrials.gov 403 Forbidden page. The study record remains unavailable.
    Difference
    1%
    Check dated 2026-10-25T12:32:40.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:22:30.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:20:05.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study details, indicating an access-restriction page is being served.
    Difference
    17%
    Check dated 2026-09-20T19:59:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.